摘要: Infection prophylaxis in high-risk patients has been evaluated a variety of diseases. Both bacteria and fungi may be targeted. Among the most extensively studied populations are with hematological malignancies those admitted to intensive care unit. The effectiveness ecological impact infection remain actively debated.
springer.com
sci-hub.st 参考文章(23)
S. Mousset, G. Bug, W.J. Heinz, K. Tintelnot, V. Rickerts, Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation. Transplant Infectious Disease. ,vol. 12, pp. 261- 264 ,(2009) , 10.1111/J.1399-3062.2009.00479.X
Evelien A. N. Oostdijk, Anne Marie G. A. de Smet, Hetty E. M. Blok, Emily S. Thieme Groen, Gerard J. van Asselt, Robin F. J. Benus, Sandra A. T. Bernards, Ine H. M. E. Frénay, Arjan R. Jansz, Bartelt M. de Jongh, Jan A. Kaan, Maurine A. Leverstein-van Hall, Ellen M. Mascini, Wouter Pauw, Patrick D. J. Sturm, Steven F. T. Thijsen, Jan A. J. W. Kluytmans, Marc J. M. Bonten, Ecological Effects of Selective Decontamination on Resistant Gram-negative Bacterial Colonization American Journal of Respiratory and Critical Care Medicine. ,vol. 181, pp. 452- 457 ,(2010) , 10.1164/RCCM.200908-1210OC
F Schlemmer, M Lagrange-Xélot, C Lacroix, R de La Tour, G Socié, J-M Molina, Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation. Bone Marrow Transplantation. ,vol. 42, pp. 551- 552 ,(2008) , 10.1038/BMT.2008.199
Paolo Manzoni, MariaLisa Leonessa, Paolo Galletto, Maria Agnese Latino, Riccardo Arisio, Milena Maule, Giovanni Agriesti, Luca Gastaldo, Elena Gallo, Michael Mostert, Daniele Farina, Routine Use of Fluconazole Prophylaxis in a Neonatal Intensive Care Unit Does Not Select Natively Fluconazole-Resistant Candida Subspecies The Pediatric Infectious Disease Journal. ,vol. 27, pp. 731- 737 ,(2008) , 10.1097/INF.0B013E318170BB0C
M Craig, A D Cumpston, G R Hobbs, M P DeVetten, A R Sarwari, S G Ericson, The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplantation. ,vol. 39, pp. 477- 482 ,(2007) , 10.1038/SJ.BMT.1705591
S. Faiz, B. Neale, E. Rios, T. Campos, E. Parsley, B. Patel, L. Ostrosky-Zeichner, Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 28, pp. 689- 692 ,(2009) , 10.1007/S10096-008-0666-4
W. V. Kern, K. Klose, A. S. Jellen-Ritter, M. Oethinger, J. Bohnert, P. Kern, S. Reuter, H. Baum, R. Marre, Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 24, pp. 111- 118 ,(2005) , 10.1007/S10096-005-1278-X
R Trenschel, R Peceny, V Runde, A Elmaagacli, H Dermoumi, EHeintschel von Heinegg, K-D Müller, UW Schaefer, DW Beelen, Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplantation. ,vol. 26, pp. 993- 997 ,(2000) , 10.1038/SJ.BMT.1702655
Shelley S. Magill, Sandra M. Swoboda, Christine E. Shields, Elizabeth A. Colantuoni, Annette W. Fothergill, William G. Merz, Pamela A. Lipsett, Craig W. Hendrix, The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. Annals of Surgery. ,vol. 249, pp. 657- 665 ,(2009) , 10.1097/SLA.0B013E31819ED914
M. Bassetti, F. Ansaldi, L. Nicolini, E. Malfatto, M. P. Molinari, M. Mussap, B. Rebesco, F. Bobbio Pallavicini, G. Icardi, C. Viscoli, Incidence of candidaemia and relationship with fluconazole use in an intensive care unit Journal of Antimicrobial Chemotherapy. ,vol. 64, pp. 625- 629 ,(2009) , 10.1093/JAC/DKP251